FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2610929028> ?p ?o ?g. }

• W2610929028 endingPage "770" @default.
• W2610929028 startingPage "757" @default.
• W2610929028 abstract "Despite recent advances in chemotherapy, aggressive and metastatic breast cancers remain refractory to targeted therapy and the development of novel drugs is urgently needed. Retinoids are crucial regulators of cellular proliferation, differentiation, and cell death, and have shown potent chemotherapeutic and chemopreventive properties. The major drawback of the use of all-trans retinoic acid (ATRA) in cancer therapy is disease relapse. Therefore, synthetic retinoids, specifically ST1926, have emerged as potent anticancer agents. Given the importance of the microenvironment in modulating the response of cancer cells to chemotherapeutic drugs, we investigated the antitumor activities of ST1926 in two-dimensional (2D) and different three-dimensional (3D) human breast cancer models and compared them with ATRA. We have shown that in 2D cell culture models, ATRA-resistant MCF-7 and MDA-MB-231 cells were sensitive to ST1926 at submicromolar concentrations that spared the ‘normal-like’ breast epithelial cells. ST1926 induced apoptosis and S-phase arrest, caused DNA damage, and downregulated the Wnt/β-catenin pathway in breast cancer cells in 2D and 3D cell culture models. ST1926-mediated growth inhibition was independent of the retinoid receptor-signaling pathway. Long-term treatments with low submicromolar ST1926 concentrations reduced the anchorage-independent growth and decreased the sphere-forming ability of breast cancer progenitor cells in the sphere formation assay. Furthermore, ST1926 potently induced cell death of breast cancer cells under 3D conditions and spared the lumen-forming ability of normal-like breast epithelial cells. In tested 3D models, ATRA had minimal effects on the growth of breast cancer cells compared with ST1926. In summary, our results highlight the therapeutic potential of ST1926 in breast cancer and warrant its further clinical development." @default.
• W2610929028 created "2017-05-12" @default.
• W2610929028 creator A5016187998 @default.
• W2610929028 creator A5026395749 @default.
• W2610929028 creator A5038584483 @default.
• W2610929028 creator A5045670524 @default.
• W2610929028 creator A5055444545 @default.
• W2610929028 creator A5057591939 @default.
• W2610929028 creator A5062689471 @default.
• W2610929028 creator A5085969774 @default.
• W2610929028 date "2017-08-01" @default.
• W2610929028 modified "2023-09-30" @default.
• W2610929028 title "Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models" @default.
• W2610929028 cites W1757407923 @default.
• W2610929028 cites W1967293289 @default.
• W2610929028 cites W1973874596 @default.
• W2610929028 cites W1977587477 @default.
• W2610929028 cites W1978703495 @default.
• W2610929028 cites W1980324695 @default.
• W2610929028 cites W1983051794 @default.
• W2610929028 cites W1995014573 @default.
• W2610929028 cites W1996331246 @default.
• W2610929028 cites W1999374869 @default.
• W2610929028 cites W2026309875 @default.
• W2610929028 cites W2027366992 @default.
• W2610929028 cites W2042811139 @default.
• W2610929028 cites W2045399619 @default.
• W2610929028 cites W2052279665 @default.
• W2610929028 cites W2062367187 @default.
• W2610929028 cites W2064402415 @default.
• W2610929028 cites W2076167086 @default.
• W2610929028 cites W2084522996 @default.
• W2610929028 cites W2097255042 @default.
• W2610929028 cites W2098536987 @default.
• W2610929028 cites W2107994994 @default.
• W2610929028 cites W2113680845 @default.
• W2610929028 cites W2116315632 @default.
• W2610929028 cites W2127362646 @default.
• W2610929028 cites W2128920415 @default.
• W2610929028 cites W2139967844 @default.
• W2610929028 cites W2140187740 @default.
• W2610929028 cites W2148403640 @default.
• W2610929028 cites W2151397402 @default.
• W2610929028 cites W2154045200 @default.
• W2610929028 cites W2159159025 @default.
• W2610929028 cites W2167215860 @default.
• W2610929028 cites W2170824891 @default.
• W2610929028 cites W2182224080 @default.
• W2610929028 cites W2331628193 @default.
• W2610929028 cites W2407520682 @default.
• W2610929028 cites W2529254819 @default.
• W2610929028 cites W2570618306 @default.
• W2610929028 cites W625441648 @default.
• W2610929028 doi "https://doi.org/10.1097/cad.0000000000000511" @default.
• W2610929028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28471809" @default.
• W2610929028 hasPublicationYear "2017" @default.
• W2610929028 type Work @default.
• W2610929028 sameAs 2610929028 @default.
• W2610929028 citedByCount "17" @default.
• W2610929028 countsByYear W26109290282017 @default.
• W2610929028 countsByYear W26109290282018 @default.
• W2610929028 countsByYear W26109290282019 @default.
• W2610929028 countsByYear W26109290282020 @default.
• W2610929028 countsByYear W26109290282021 @default.
• W2610929028 countsByYear W26109290282022 @default.
• W2610929028 countsByYear W26109290282023 @default.
• W2610929028 crossrefType "journal-article" @default.
• W2610929028 hasAuthorship W2610929028A5016187998 @default.
• W2610929028 hasAuthorship W2610929028A5026395749 @default.
• W2610929028 hasAuthorship W2610929028A5038584483 @default.
• W2610929028 hasAuthorship W2610929028A5045670524 @default.
• W2610929028 hasAuthorship W2610929028A5055444545 @default.
• W2610929028 hasAuthorship W2610929028A5057591939 @default.
• W2610929028 hasAuthorship W2610929028A5062689471 @default.
• W2610929028 hasAuthorship W2610929028A5085969774 @default.
• W2610929028 hasConcept C121608353 @default.
• W2610929028 hasConcept C126322002 @default.
• W2610929028 hasConcept C137620995 @default.
• W2610929028 hasConcept C185592680 @default.
• W2610929028 hasConcept C190283241 @default.
• W2610929028 hasConcept C2775954498 @default.
• W2610929028 hasConcept C2781121885 @default.
• W2610929028 hasConcept C31573885 @default.
• W2610929028 hasConcept C502942594 @default.
• W2610929028 hasConcept C530470458 @default.
• W2610929028 hasConcept C54355233 @default.
• W2610929028 hasConcept C55493867 @default.
• W2610929028 hasConcept C62112901 @default.
• W2610929028 hasConcept C62478195 @default.
• W2610929028 hasConcept C71924100 @default.
• W2610929028 hasConcept C81885089 @default.
• W2610929028 hasConcept C86803240 @default.
• W2610929028 hasConcept C95444343 @default.
• W2610929028 hasConcept C96232424 @default.
• W2610929028 hasConceptScore W2610929028C121608353 @default.
• W2610929028 hasConceptScore W2610929028C126322002 @default.
• W2610929028 hasConceptScore W2610929028C137620995 @default.
• W2610929028 hasConceptScore W2610929028C185592680 @default.

• next